Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoHealth (GOCO) EBIT Margin (2019 - 2025)

GoHealth's EBIT Margin history spans 7 years, with the latest figure at 842.21% for Q3 2025.

  • For Q3 2025, EBIT Margin fell 80613.0% year-over-year to 842.21%; the TTM value through Sep 2025 reached 40.68%, down 3016.0%, while the annual FY2024 figure was 0.88%, 1024.0% up from the prior year.
  • EBIT Margin for Q3 2025 was 842.21% at GoHealth, down from 105.68% in the prior quarter.
  • Across five years, EBIT Margin topped out at 20.63% in Q4 2024 and bottomed at 842.21% in Q3 2025.
  • The 5-year median for EBIT Margin is 28.76% (2023), against an average of 78.94%.
  • The largest annual shift saw EBIT Margin skyrocketed 19741bps in 2023 before it crashed -80613bps in 2025.
  • A 5-year view of EBIT Margin shows it stood at 94.12% in 2021, then crashed by -104bps to 191.97% in 2022, then skyrocketed by 103bps to 5.44% in 2023, then surged by 279bps to 20.63% in 2024, then plummeted by -4183bps to 842.21% in 2025.
  • Per Business Quant, the three most recent readings for GOCO's EBIT Margin are 842.21% (Q3 2025), 105.68% (Q2 2025), and 3.02% (Q1 2025).